Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Open accessThe DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age. Its heterogeneous clinical presentation is characterized by hyperandrogenemia, reproductive changes, polycystic ovary morphology, and insulin resistance (IR). The primary pathophysiological process in its multifactorial etiology has not yet been identified. However, the two most proposed core etiologies are the disruption of insulin metabolism and hyperandrogenemia, both of which begin to intertwine and propagate each other in the later stages of the disease. Insulin metabolism can be viewed as the interconnectedness of beta cell function, IR or insulin sensitivity, and insulin clearance. Previous studies of insulin metabolism in PCOS patients have yielded conflicting results, and literature reviews have focused mainly on the molecular mechanisms and clinical implications of IR. In this narrative review, we comprehensively explored the role of insulin secretion, clearance, and decreased sensitivity in target cells as a potential primary insult in PCOS pathogenesis, along with the molecular mechanism behind IR in PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The insulin resistance in PCOS might also occur independently of body weight, due to inherited post-receptor defects in insulin signalling that affects metabolism and mitotic pathways, not only in classic insulin target tissues, such as skeletal muscle, liver, and adipose tissue, but also in the non-classical target tissues, such as pituitary and ovary [12, 16].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hyperinsulinemia is closely involved in key steps of the pathogenesis of PCOS and hyperandrogenism [9–12].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · cited 1×
“Thus, insulin-resistant tissues exhibit decreased responsiveness and sensitivity to insulin stimulation, whereas this effect is more pronounced in PCOS patients than in obese patients [60,61].”
BackgroundInsulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458 · cited 1×
“The clinical presentation of PCOS patients is influenced by other insulin related systemic effects through modulation of the luteinizing hormone pulse amplitude, stimulation of adrenal androgen secretion, and the suppression of hepatic sex hormone binding globulin production, which increases the amount of free testost…”
BackgroundAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · cited 2×
“However, with disease progression, relative or absolute insulin deficiency presents as prediabetes or T2D in the predisposed patients [10].”
BackgroundMethodProfound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
BURGHEN, G. A., GIVENS, J. R., & KITABCHI, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919 · cited 1×
“The coexistence of IR and PCOS was first described in 1980, when it was demonstrated that hyperandrogenism correlates with hyperinsulinism in women with PCOS [7].”
BackgroundInsulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871 · cited 1×
“MCRI is determined by the efficiency of the insulin degradation process, which involves the internalization of the insulin-receptor complex and is followed by insulin degradation in the cytoplasm, carried out by insulin-degrading enzyme and other lysosomal enzymes [84,85].”
BackgroundChen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690 · cited 4×
“I paired PI3 activity ay lead to a decreased activation of P B, the ain enzy e for propagating the tra slocatio of GLUT4 to the cell membrane, resulting in reduced insulin-i duced glucose uptake in target tissues [71].”
BackgroundInfluentialGenome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678
The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review
Pundir, C., Deswal, R., Narwal, V., & Dang, A. (2020) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_95_18 · Cited by 657 · cited 1×
“It affects up to 20% of women worldwide, and its prevalence has been on the rise over the last decade [1].”
BackgroundDay, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
The Molecular Basis for Oxidative Stress-Induced Insulin Resistance
Evans, J. L., Maddux, B. A., & Goldfine, I. D. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1040 · Cited by 587
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 4×
“Adipocytes from PCOS patients exhibit a normal number and affinity of insulinbinding sites on their cell surface, indicating a defect downstream from the insulin receptor [60,66].”
BackgroundInfluentialEvidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Shelley, D. R., Green, G., Dobrjansky, A., & Licholai, T. (1992) · Diabetes · doi:10.2337/diab.41.10.1257 · Cited by 546 · cited 1×
“Adipocytes from PCOS patients exhibit a normal number and affinity of insulinbinding sites on their cell surface, indicating a defect downstream from the insulin receptor [60,66].”
BackgroundHayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478
Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism
Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02153 · Cited by 399
Induction of insulin resistance by androgens and estrogens
Polderman, K. H. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.265 · Cited by 380 · cited 2×
“iological androgen administration in women [38,39], and that IR can be partially reversed”
BackgroundDysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
Liu, R., Zhang, C., Shi, Y., Zhang, F., Li, L., Wang, X., Ling, Y., Fu, H., Dong, W., Shen, J., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00324 · Cited by 367
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337 · cited 2×
“When looking at the signaling downstream of IRS, IRS-1-associated activation of PI3K was decreased in the skeletal muscles of women with PC S [70].”
BackgroundHyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322 · cited 1×
“Both begin to notably intertwine and propagate each other in the later stages of the disease [4].”
BackgroundTakayama, S., White, M. F., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69090-8 · Cited by 317 · cited 1×
“The constitutive phosphorylation of serine residues of the beta-subunit of the insulin receptor and IRS-1 Ser312, observed in higher levels in tissues of PCOS patients, impede the tyrosine phosphorylation of both the insulin receptor and IRS-1 after insulin stimulation [67,68].”
BackgroundGut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity
Insenser, M., Murri, M., del Campo, R., Martínez-García, M. Á., Fernández-Durán, E., & Escobar-Morreale, H. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02799 · Cited by 312
Nolan, C. J., & Prentki, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827611 · Cited by 292 · cited 9×
“However, with disease progression, relative or absolute insulin deficiency presents as prediabetes or T2D in the predisposed patients [10].”
BackgroundInfluentialHolte, J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1052 · Cited by 290 · cited 1×
“Interestingly, the same method demonstrated the presence of hyperinsulinemia in lean PCOS patients with normal insulin sensitivity, and even higher insulin secretion in lean patients than in obese patients or controls [15,16].”
MethodHe, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289 · cited 3×
“Besides the data indicating that microbiome composition can mediate the synthesis and secretion of insulin from beta cells, there is also some data that it affects androgen metabolism and follicular development [46].”
BackgroundInfluentialCorbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283 · cited 1×
“The constitutive phosphorylation of serine residues of the beta-subunit of the insulin receptor and IRS-1 Ser312, observed in higher levels in tissues of PCOS patients, impede the tyrosine phosphorylation of both the insulin receptor and IRS-1 after insulin stimulation [67,68].”
BackgroundXu, Y., & Qiao, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9240569 · Cited by 283
Willis, D. S., Watson, H., Mason, H. D., Galea, R., Brincat, M., & Franks, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5232 · Cited by 269
Free–Fatty Acid Inhibition of Insulin Binding, Degradation, and Action in Isolated Rat Hepatocytes
Svedberg, J., Björntorp, P., Smith, U., & Lönnroth, P. (1990) · Diabetes · doi:10.2337/diab.39.5.570 · Cited by 263
Insulin and the polycystic ovary syndrome
Macut, D., Bjekić-Macut, J., Rahelić, D., & Doknić, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.011 · Cited by 261 · cited 4×
“I paired PI3 activity ay lead to a decreased activation of P B, the ain enzy e for propagating the tra slocatio of GLUT4 to the cell membrane, resulting in reduced insulin-i duced glucose uptake in target tissues [71].”
BackgroundInfluentialPolycystic ovary syndrome and mitochondrial dysfunction
Zhang, J., Bao, Y., Zhou, X., & Zheng, L. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0509-4 · Cited by 258 · cited 2×
“which are involved in regulation of cellular ATP and reactive oxygen species levels [72].”
BackgroundMoghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.952 · Cited by 245 · cited 2×
“supraphysiological androgen administration in women [38,39], and that IR can be partially reversed by androgen suppression or antiandrogen treatment [40,41].”
BackgroundDefects in beta-cell function in functional ovarian hyperandrogenism
O'Meara, N. M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1241 · Cited by 245
Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., & Tapanainen, J. S. (2000) · Human Reproduction · doi:10.1093/humrep/15.6.1266 · Cited by 227
Nolan, C. J., Ruderman, N. B., Kahn, S. E., Pedersen, O., & Prentki, M. (2015) · Diabetes · doi:10.2337/db14-0694 · Cited by 226 · cited 6×
“Thus, the frequently observed IR in the pathogenesis of metabolic diseases could be seen as a protective cell mechanism against glucolipotoxicity in the state of constant positive energy balance by limiting the entry of excess glucose in the cells at times of concomitant high free fatty acid availability [25].”
BackgroundInfluentialShould all women with PCOS be treated for insulin resistance?
Marshall, J. C., & Dunaif, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 217 · cited 1×
“Still, the improvement in insulin sensitivity remains one of the primary desired treatment outcomes in most interventions, since extensive data reinforce the correlation between improved insulin sensitivity and other beneficial metabolic and reproductive outcomes [22,23].”
BackgroundInsulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209 · cited 3×
“Although there is a fair amount of data on the degree and prevalence of IR in women with PCOS, as well as some information on insulin secretion, MCRI was rarely investigated [21].”
BackgroundInfluentialWillis, D. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.3984 · Cited by 206
Skov, V., Glintborg, D., Knudsen, S., Jensen, T., Kruse, T. A., Tan, Q., Brusgaard, K., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db07-0275 · Cited by 205 · cited 2×
“duction of reactive oxygen species [73,74].”
BackgroundGoodarzi, M. O., Jones, M. R., Li, X., Chua, A. K., Garcia, O. A., Chen, Y.-D. I., Krauss, R. M., Rotter, J. I., Ankener, W., Legro, R. S., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100427 · Cited by 199
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Corbould, A., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166 · cited 3×
“In patients with PCOS, IR selectively affects only the PI3K pathway, while the MAPK pathway functions normally [62,63].”
BackgroundMicrobiome and PCOS: State-of-Art and Future Aspects
Giampaolino, P., Foreste, V., Di Filippo, C., Gallo, A., Mercorio, A., Serafino, P., Improda, F. P., Verrazzo, P., Zara, G., Buonfantino, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042048 · Cited by 163 · cited 4×
“It is also vital to take into account that hyperandrogenemia has multiple direct effects on intestinal microbiota composition [5,6].”
BackgroundInfluentialLean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154 · cited 1×
“In addition, although the initial studies in the 1980s showed increased levels of IR in lean PCOS patients, many conflicting results were later reported, and the described prevalence of IR is generally lower than that in overweight or obese patients [24].”
ResultInsulin Resistance in Nonobese Patients with Polycystic Ovary Syndrome
Toprak, S., Yönem, A., Çakır, B., Güler, S., Azal, Ö., Özata, M., & Çorakçı, A. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049972 · Cited by 152
Insulin Sensitivity in Women with Polycystic Ovary Syndrome
VrbÍková, J., Cibula, D., Dvor̆áková, K., Stanická, S., Šindelka, G., Hill, M., Fanta, M., Vondra, K., & Škrha, J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031378 · Cited by 147
Yki-Järvinen, H., Mäkimattila, S., Utriainen, T., & Rutanen, E. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593430 · Cited by 146
Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome
Ovesen, P. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1636 · Cited by 138
Colilla, S., Cox, N. J., & Ehrmann, D. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7518 · Cited by 129 · cited 1×
“The authors demonstrated no evidence of sibling correlation in IR; however, impaired beta cell secretion was significantly correlated between both groups, as well as the parameter quantitating insulin secretion in relation to insulin sensitivity [52].”
BackgroundCross-Ethnic Meta-Analysis of Genetic Variants for Polycystic Ovary Syndrome
Louwers, Y. V., Stolk, L., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2495 · Cited by 128 · cited 2×
“Several genome-wide association studies have be n performed to explor the geneti architecture of PCOS [77–82], and the results showed that genes associated with gonadotropin function may be involved in PCOS developme t, and that genetic variants associated with PCOS are shared between ethnic groups [77,82].”
BackgroundType 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis
Escobar-Morreale, H. F., & Roldán-Martín, M. B. (2016) · Diabetes Care · doi:10.2337/dc15-2577 · Cited by 123
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund, K. (2014) · PubMed · Cited by 117
Barber, T. M., Dimitriadis, G. K., Andreou, A., & Franks, S. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s72 · Cited by 116 · cited 4×
“Moreover, insulin mediates follicular development, promoting the arrest of pre-antral follicle development in the setting of hyperinsulinemia [9,17,18].”
BackgroundInfluentialCiampelli, M., Fulghesu, A. M., Cucinelli, F., Pavone, V., Caruso, A., Mancuso, S., & Lanzone, A. (1997) · Human Reproduction · doi:10.1093/humrep/12.9.1897 · Cited by 115 · cited 1×
“The authors concluded that IR seems to be more dependent on obesity, while hyperinsulinemia is a primary feature of PCOS [93].”
BackgroundLi, M., Youngren, J. F., Dunaif, A., Goldfine, I. D., Maddux, B. A., Zhang, B. B., & Evans, J. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020363 · Cited by 112 · cited 2×
“inhibitors enhanced the tyrosine autophosphorylation of the insulin receptor [69], sug-”
BackgroundEffects of Methyltestosterone on Insulin Secretion and Sensitivity In Women1
Diamond, M. P., Grainger, D., Diamond, M. C., Sherwin, R. S., & DeFronzo, R. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5333 · Cited by 104 · cited 2×
“iological androgen administration in women [38,39], and that IR can be partially reversed”
BackgroundDiao, F., Xu, M., Hu, Y., Li, J., Xu, Z., Lin, M., Wang, L., Zhou, Y., Zhou, Z., Liu, J., et al. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330059 · Cited by 101
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
Goodarzi, M. O., Erickson, S., Port, S. C., Jennrich, R. I., & Korenman, S. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1006 · Cited by 99
Mumusoglu, S., & Yildiz, B. O. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.03.004 · Cited by 98 · cited 1×
“Three diagnostic criteria sets are commonly used to divide the syndrome into four distinct phenotypes [3].”
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
Amato, M. C., Vesco, R., Vigneri, E., Ciresi, A., & Giordano, C. S. D. S. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0372-x · Cited by 98 · cited 5×
“Along with the interpretation of peripheral levels of insulin that are most often used in the evaluation of insulin secretion and in the estimation of the degree of IR, it is essential to take into account that peripheral insulin levels do not always provide an appropriate approximation of portal insulin levels and do…”
BackgroundInfluentialGenome-wide association study identified new susceptibility loci for polycystic ovary syndrome
Lee, H., Oh, J.-Y., Sung, Y.-A., Chung, H., Kim, H.-L., Kim, G. S., Cho, Y. S., & Kim, J. T. (2015) · Human Reproduction · doi:10.1093/humrep/deu352 · Cited by 97 · cited 2×
“Several genome-wide association studies have be n performed to explor the geneti architecture of PCOS [77–82], and the results showed that genes associated with gonadotropin function may be involved in PCOS developme t, and that genetic variants associated with PCOS are shared between ethnic groups [77,82].”
BackgroundEffects of Free Fatty Acids and Glucose on Splanchnic Insulin Dynamics
Hennes, M. M. I., Dua, A., & Kissebah, A. H. (1997) · Diabetes · doi:10.2337/diab.46.1.57 · Cited by 95
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states
Taegtmeyer, H., Beauloye, C., Harmancey, R., & Hue, L. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00854.2012 · Cited by 95
Evidence for Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease
JIALAL, I., NAIKER, P., REDDI, K., MOODLEY, J., & JOUBERT, S. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1066 · Cited by 92 · cited 1×
“A few years later, a small study found that even lean patients with PCOS are insulin resistant [8], which paved the way to the hypothesis that IR might be central to PCOS.”
BackgroundAndrogen and glucocorticoid receptors interact with insulin degrading enzyme.
Kupfer, S. R., Wilson, E. M., & French, F. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32038-0 · Cited by 86
Skov, V., Glintborg, D., Knudsen, S., Tan, Q., Jensen, T., Kruse, T. A., Beck-Nielsen, H., & Højlund, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002466 · Cited by 84 · cited 2×
“duction of reactive oxygen species [73,74].”
BackgroundInsulin Sensitivity and β-Cell Function in Women With Polycystic Ovary Syndrome
Vrbíková, J., Bendlová, B., Hill, M., Vanková, M., Vondra, K., & Stárka, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1217 · Cited by 80
Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors
Kupfer, S. R., Marschke, K. B., Wilson, E. M., & French, F. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85364-4 · Cited by 79
Mechanism of insulin resistance in obesity: a role of ATP
Ye, J. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0862-5 · Cited by 77 · cited 4×
“ATP overproduction can potentially lead to IR through multiple mechanisms, such as the inhibition of AMPK, the induction of mTOR, and mitochondrial dysfunction, representing a feedback regulation of energy oversupply [30].”
BackgroundInfluentialEffects of Methyltestosterone on Insulin Secretion and Sensitivity In Women
Diamond, M. P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.12.4420 · Cited by 75
Colilla, S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2027 · Cited by 67
Dahan, M. H., & Reaven, G. (2019) · Endocrine · doi:10.1007/s12020-019-01899-9 · Cited by 62 · cited 1×
“Despite numerous studies investigating the relationship between excess weight, decreased insulin sensitivity, and hyperinsulinemia in women with PCOS, our understanding of this multidirectional and synergistic web of interactions remains unclear [11].”
BackgroundInsulin resistance improves in hyperandrogenic women treated with Lupron
Elkind-Hirsch, K. E., Valdés, C. T., & Malinak, L. R. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56213-x · Cited by 61
Rae, M., Grace, C., Hogg, K., Wilson, L. M., McHaffie, S. L., Ramaswamy, S., MacCallum, J., Connolly, F., McNeilly, A. S., & Duncan, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056263 · Cited by 53 · cited 1×
“This data supports the group’s previous findings that in the ovine and rhesus monkey model, abnormal pancreatic function likely precedes the development of IR and places hyperinsulinemia upstream [56,57].”
ResultRajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz-Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J. R., & Sutherland, C. (2009) · Biochemical Journal · doi:10.1042/bj20082176 · Cited by 53 · cited 2×
“In patients with PCOS, IR selectively affects only the PI3K pathway, while the MAPK pathway functions normally [62,63].”
BackgroundJensterle, M., Herman, R., & Janež, A. (2022) · Biomedicines · doi:10.3390/biomedicines10081989 · Cited by 50 · cited 1×
“The new era of anti-obesity therapy offers a novel powerful pharmacologic tool to improve metabolic, reproductive, and other clinical outcomes in a subset of patients who are overweight or obese, primarily through weight reduction [2].”
BackgroundSelf-citationEvidence for pancreatic β-cell dysfunction in brothers of women with polycystic ovary syndrome
Sam, S., Sung, Y., Legro, R. S., & Dunaif, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2007.08.010 · Cited by 48 · cited 1×
“Similarly, one study also found unexpectedly low insulin secretion when corrected for peripheral insulin sensitivity in brothers of women with PCOS compared to control men [53].”
ResultBuffington, C. K., & Kitabchi, A. E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90029-9 · Cited by 42 · cited 1×
“Furthermore, basal C-peptide to insulin ratios and insulin-degradative activities were significantly and negatively interrelated, and both those parameters were highly correlated with basal testosterone levels [92].”
BackgroundAbnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys
Nicol, L. E., O’Brien, T. D., Dumesic, D. A., Grogan, T., Tarantal, A. F., & Abbott, D. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106527 · Cited by 41 · cited 1×
“This data supports the group’s previous findings that in the ovine and rhesus monkey model, abnormal pancreatic function likely precedes the development of IR and places hyperinsulinemia upstream [56,57].”
ResultRamaswamy, S., Grace, C., Mattei, A. A., Siemienowicz, K., Brownlee, W., MacCallum, J., McNeilly, A. S., Duncan, W. C., & Rae, M. T. (2016) · Scientific Reports · doi:10.1038/srep27408 · Cited by 41
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178120 · Cited by 40 · cited 1×
“Women with PCOS showed higher IR and beta cell function than the controls, but not when lean patients were compared to matched controls separately [48].”
ResultLiu, Y., Li, J., Yan, Z., Liu, D., Ma, J., & Tong, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.657889 · Cited by 39 · cited 1×
“Still, the improvement in insulin sensitivity remains one of the primary desired treatment outcomes in most interventions, since extensive data reinforce the correlation between improved insulin sensitivity and other beneficial metabolic and reproductive outcomes [22,23].”
BackgroundConnor, T., Martin, S. D., Howlett, K. F., & McGee, S. L. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12315 · Cited by 37
Intensive insulin for type 2 diabetes: the risk of causing harm
Nolan, C. J., Ruderman, N. B., & Prentki, M. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70027-5 · Cited by 37
Amato, M. C., Guarnotta, V., Ciresi, A., Modica, R., Pantò, F., & Giordano, C. S. D. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2669 · Cited by 37
Manco, M., Castagneto-Gissey, L., Arrighi, E., Carnicelli, A., Brufani, C., Luciano, R., & Mingrone, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092995 · Cited by 37 · cited 2×
“When comparing their insulin metabolism with that of the IR-matched controls higher fasting and total insulin secretion was observed in PCOS patients than that of their peers [34].”
ResultGennarelli, G., Rovei, V., Novi, R. F., Holte, J., Bongioanni, F., Revelli, A., Pacini, G., Cavallo‐Perin, P., & Massobrio, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1973 · Cited by 37 · cited 1×
“On the other hand, by comparing normal-weight women with PCOS and no family history of T2D with normally ovulating women, matched for age and BMI, insulin sensitivity and insulin secretion were similar between two groups [49].”
BackgroundTosi, F., Molin, F. D., Zamboni, F., Saggiorato, E., Salvagno, G. L., Fiers, T., Kaufman, J., Bonora, E., & Moghetti, P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa095 · Cited by 33 · cited 3×
“MCRI is determined by the efficiency of the insulin degradation process, which involves the internalization of the insulin-receptor complex and is followed by insulin degradation in the cytoplasm, carried out by insulin-degrading enzyme and other lysosomal enzymes [84,85].”
BackgroundRelease of Immunoreactive Insulin from the Human Heart
Wahlqvist, M. L., Kaijser, L., Lassers, B. W., Löw, H., & Carlson, L. A. (1972) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1972.tb00669.x · Cited by 19
Thong, E. P., Milat, F., Joham, A. E., Mishra, G. D., & Teede, H. J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14281 · Cited by 17
Early impaired β-cell function in chinese women with polycystic ovary syndrome.
Tao, T., Li, S., Zhao, A., Mao, X., & Liu, W. (2012) · Europe PMC (PubMed Central) · Cited by 15
β cell function and insulin resistance in lean cases with polycystic ovary syndrome
Pande, A. K., Guleria, A., Singh, S. D., Shukla, M. K., & Dabadghao, P. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1342165 · Cited by 13 · cited 1×
“Beta cell activity was the highest in the lean PCOS group; however, no difference was observed between the other two groups [47].”
BackgroundEffect of lactate on hepatic insulin clearance in perfused rat liver
Pagano, C., Rizzato, M. D., Lombardi, A. M., Fabris, R., Favaro, A., Federspil, G., & Vettor, R. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.270.3.r682 · Cited by 11
(1996) · Springer eBooks · doi:10.1007/978-1-4613-8483-0 · Cited by 7
Stassek, J., Erdmann, J., Ohnolz, F., Berg, F., Kiechle, M. B., & Seifert‐Klauss, V. (2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0042-119199 · Cited by 5
Wang, Z. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83161 · Cited by 4
Lin, Q., Zhang, H., Zhao, J.-H., & Wang, Z. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89246 · Cited by 3 · cited 1×
“I paired PI3 activity ay lead to a decreased activation of P B, the ain enzy e for propagating the tra slocatio of GLUT4 to the cell membrane, resulting in reduced insulin-i duced glucose uptake in target tissues [71].”
BackgroundBeta-Cell Function in Polycystic Ovary Syndrome
Ehrmann, D. A., Sturis, J., Byrne, M. M., Rosenfield, R. L., & Polonsky, K. S. (1996) · Springer eBooks · doi:10.1007/978-1-4613-8483-0_9 · Cited by 1 · cited 1×
“However, when first-phase insulin secretion was analyzed by taking into account either the degree of IR or basal insulin secretion, they found that women with PCOS who have a family history of diabetes were significantly more likely to demonstrate impairments in beta cell function [50].”
Method
Cited by
Yang, J., & Chen, C. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0342 · Cited by 169
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Deng, H., Chen, Y., Xing, J., Zhang, N., & Xu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470283 · Cited by 168
Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
Wang, K., & Lǐ, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191759 · Cited by 127
“Obesity may aggravate IR: overall, it promotes insulin secretion while repressing its clearance and degradation (11).”
BackgroundMacrophages: a double-edged sword in female reproduction and disorders
Park, M., Kim, Y. S., & Song, H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01392-6 · Cited by 82
“This disturbed condition can affect glucose uptake in the endometrium and cause fertility failure in these women 52 .”
Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K., & Jafari, S. M. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10223-5 · Cited by 51
Metadata
- Authors
- Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V.
- Affiliations
- University of Ljubljana (SI)
- Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia
- Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-02-05
- Volume
- 24
- Issue
- 4
- Pages
- 3140
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9962893
- OpenAlex
- W4319318242
- Cited by
- 69
- References
- 97
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 16 · 2023: 12
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Slovenian Research Agency (ARRS) (P1-0170, P3-0298)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- polycystic ovary syndrome, insulin metabolism, insulin resistance, insulin secretion, insulin clearance, beta-cell function, hyperandrogenemia, insulin signaling, PCOS pathogenesis
- MeSH terms
- Female, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Signal Transduction, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.